MREOMereo BioPharma Group plc American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key: 18745
Ticker: MREO
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-04-24
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MREO

Detail

Enriched 2026-08-14 20:47

Market cap: $48,348,476.67
Shares outstanding (class): 159,615,766
Shares outstanding (weighted): 159,618,609
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 39
Location: LONDON
Homepage: https://www.mereobiopharma.com
Description: Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Market cap and share counts drift.

Funds holding this security

2 funds · 2 positions · $44.4K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$44.0K	0.01%	133,379 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$396.00	0.00%	1,200 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMREO
FIGI_COMPOSITEBBG00KFWZC67
FIGI_SHARE_CLASSBBG00KFWZCX7
CIK0001719714
ISINUS5894921072
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Mereo BioPharma is a biopharmaceutical company, and its SIC code 2834 indicates pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.